One Shot Ultra 7
One Shot Ultra 7
One-Shot Ultra 7 is used for vaccination of healthy cattle and sheep as an aid in preventing blackleg caused by Cl. chauvoei, malignant oedema caused by Cl. septicum; black disease caused by Cl. novyi; gas-gangrene caused by Cl. sordellii and enterotoxemia and enteritis caused by Cl. perfringens Type B, C and D, and bovine pneumonic pasteurellosis caused by Mannheimia (Pasteurella) haemolytica Type A1. One Shot Ultra 7 provides blackleg and pasteurella protection for cattle by preventing Clostridium chauvoei, septicum, novyi, sordellii, perfringens Types C & D. One shot ultra 7 also protects against the primary cause of respiratory death in cattle, shipping fever and pneumonia caused by Mannheimia haemolytica Type A1. The liquid component consists of killed, standardized cultures of Cl. chauvoei, Cl. septicum, Cl. novyi, Cl. sordellii, and Cl. perfringens types C and D, with a special, water-soluble adjuvant (Stimugen) to enhance the immune response.
One Shot Ultra 7 consists of killed, standardised cultures of Cl. chauvoei, Cl. septicum, Cl. novyi, Cl. sordellii and Cl. perfringens Type C and D (immunity against Cl. perfringens Type B is provided by the beta toxoid of Type C and the epsilon toxoid of Type D) and inactivated whole cultures of Mannheimia (Pasteurella) haemolytica propagated to increase the production of leukotoxin and capsular and cell-associated antigens, with a special, water-soluble adjuvant (Stimugen).
One Shot Ultra 7 is used for vaccination of healthy cattle and sheep as an aid in preventing blackleg caused by Cl. chauvoei, malignant oedema caused by Cl. septicum; black disease caused by Cl. novyi; gas-gangrene caused by Cl. sordellii and enterotoxemia and enteritis caused by Cl. perfringens Type B, C and D, and pneumonic pasteurellosis caused by Mannheimia (Pasteurella) haemolytica Type A1.
Do not vaccinate within 21 days before slaughter. Keep out of reach of children, uninformed persons and animals. As with most vaccines, anaphylaxis may occur after use. Initial antidote of adrenalin is recommended and should be followed with appropriate supportive therapy. Transient local swelling at injection site may occur following vaccination. This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.
Milk production may be reduced in cows or ewes for up to 6 days after vaccination, whereafter milk production will return to normal. Although this vaccine has been tested extensively under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.
Use entire contents when first opened. Sterilised syringes and needles should be used to administer this vaccine. Do not sterilise with chemicals because traces of disinfectant may inactivate the vaccine. Burn containers and all unused contents.
Cattle: Primary Vaccination: Administer a single 2 ml dose of One-Shot Ultra™ 7 to healthy cattle, followed by a second dose of UltraChoice™ 7 4 - 6 weeks later.
Sheep: Primary Vaccination: Administer a single 1 ml dose of One-Shot Ultra™ 7 to healthy sheep, followed by a second dose of UltraChoice™ 7 4 - 6 weeks later.
Manufacturer and/or Label Information
Manufacturer and/or Label Information
GENERAL INFORMATION: This product has been shown to be effective for the vaccination of healthy horses, cattle, sheep, goats, and swine against tetanus. This product was licensed prior to the requirement to establish a minimum age for use. The duration of immunity is unknown. For more information regarding efficacy and safety data, see productdata.aphis.usda.gov.
Safety in pregnant animals is unknown.
Tetanus Toxoid is prepared by detoxifying tetanus toxin in such a manner as to allow the antigenic properties to remain intact. Product is purified, concentrated and adjuvanted to provide a low dose effective immunizing agent.
Each serial is tested for purity, safety, and potency in accordance with USDA requirements.
Tetanus is caused by a neurotoxin produced by growth of Clostridium tetani, an anaerobic (lives without air) micro-organism, in necrotic tissue. Affected animals become stiff, have difficulty swallowing, and have an increased pulse rate. Breathing is labored. Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw.
Spasmodic contractions of the muscular system occur, such as contracting muscles of the jaw. Thus, the term “lockjaw” is often used. Legs and tail are often stiff with abdominal muscles contracted. Tetanus stricken animals may be unusually sensitive to light and heat. Temperature of the animal generally remains normal, elevating only shortly before death.
Protective antibody levels usually occur about two weeks after the second injection of the primary immunization series. In contrast, administration of Tetanus Antitoxin is recommended for immediate, emergency, passive treatment of exposed animals with unknown vaccination history or with signs of tetanus infection.
DIRECTIONS: Do not vaccinate within 21 days before slaughter. Store at 2-8° C. Do not freeze. Do not mix with other products. Shake well before use. Use entire contents when first opened.
PRECAUTIONS: A transitory local reaction may occur at injection site. Anaphylactoid reaction may occur following administration of products of this nature. If noted, administer adrenalin or equivalent. In case of human exposure, consult a physician.
DOSAGE & ADMINISTRATION: For primary immunization, two doses should be administered subcutaneously or intramuscularly approximately 30 days apart. Use intramuscularly for horses as local reactions are more likely to occur if injected subcutaneously.
Horses: 1 ml IM
Cattle: 1 ml SC or IM
Sheep, Goats, Swine: 0.5 ml SC or IM
Historically, annual single dose revaccination has been recommended. Contact veterinarian for advice.
OTHER INFORMATION: Contains thimerosal and formalin as preservatives. Tetanus Toxoid Concentrate is available in single dose size packaged 10 vials to the carton, and in 10 dose vials.
THE PEAK OF QUALITY SINCE 1923
VLN: 188 / PCN: 8601.00
COLORADO SERUM COMPANY, 4950 York Street, Denver, Colorado 80216
Contact us for information on other Colorado Serum Company products. Fine Veterinary Products since 1923.
FOR VETERINARY USE ONLY
10 - 1 ml vials
10 - 1 dose vials